Detalhe da pesquisa
1.
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials.
Gastroenterology
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788861
2.
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.
Ann Rheum Dis
; 76(2): 346-354, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27117698
3.
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CTP41 and reference denosumab in healthy males.
Expert Opin Biol Ther
; : 1-9, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349618
4.
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study.
BioDrugs
; 38(1): 121-131, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991693
5.
Pharmacokinetics and safety of CT-P17 (40 mg/0.4 ml) versus reference adalimumab: randomized study in healthy Japanese adults.
Immunotherapy
; 15(3): 149-161, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748363
6.
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, single-dose phase I study.
Expert Opin Investig Drugs
; 32(5): 429-439, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231670
7.
Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-κB.
Toxicol Appl Pharmacol
; 254(1): 56-64, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21515303
8.
Toxic effects of mercuric sulfide on immune organs in mice.
Immunopharmacol Immunotoxicol
; 32(2): 277-83, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20017590
9.
Galangin attenuates mast cell-mediated allergic inflammation.
Food Chem Toxicol
; 57: 209-16, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23535185